ARS Pharmaceuticals Inc XNAS: SPRY

Expensive Underperformer

Download real time

8.81 -0.69 (-7.26%)

53.39% Fall from 52W High

1.3M

XNAS Volume

XNAS 12 Feb, 2026 4:01 PM (EST)

ARS Pharma Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents